Paul van der Horst
Président chez MOLECURE S.A.
Profil
Paul van der Horst is currently the Chairman-Supervisory Board at Molecure SA, the Director at Immunetune, and the Chief Business Officer at AgomAb Therapeutics NV.
Previously, he worked as the Director of Business Development & IR at Galapagos NV and as an Analyst at Van Lanschot Kempen NV (Broker).
He holds a doctorate degree from Erasmus University Rotterdam.
Postes actifs de Paul van der Horst
Sociétés | Poste | Début |
---|---|---|
MOLECURE S.A. | Président | - |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
Immunetune | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul van der Horst
Sociétés | Poste | Fin |
---|---|---|
GALAPAGOS NV | Public Communications Contact | 01/04/2021 |
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Analyst-Equity | - |
Formation de Paul van der Horst
Erasmus University Rotterdam | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GALAPAGOS NV | Health Technology |
MOLECURE S.A. | Health Technology |
Entreprise privées | 3 |
---|---|
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Finance |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
Immunetune |